Vir Biotechnology, Inc. (VIR)
11.70
+0.58
(+5.22%)
USD |
NASDAQ |
Oct 09, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Profit Margin (Quarterly) : 33.51% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.51% |
| March 31, 2026 | |
| December 31, 2025 | -66.99% |
| September 30, 2025 | -67.98K% |
| June 30, 2025 | -9.14K% |
| March 31, 2025 | -3.99K% |
| December 31, 2024 | -845.2% |
| September 30, 2024 | -8.98K% |
| June 30, 2024 | -4.50K% |
| March 31, 2024 | -115.8% |
| December 31, 2023 | -690.9% |
| September 30, 2023 | -6.19K% |
| June 30, 2023 | -5.13K% |
| March 31, 2023 | -223.9% |
| December 31, 2022 | -205.6% |
| September 30, 2022 | 46.81% |
| Date | Value |
|---|---|
| June 30, 2022 | |
| March 31, 2022 | 42.08% |
| December 31, 2021 | 64.63% |
| September 30, 2021 | |
| June 30, 2021 | 34.91% |
| March 31, 2021 | -8.55K% |
| December 31, 2020 | -6.09K% |
| September 30, 2020 | -4.39K% |
| June 30, 2020 | -46.53% |
| March 31, 2020 | -1.35K% |
| December 31, 2019 | -6.51K% |
| September 30, 2019 | -3.44K% |
| June 30, 2019 | -1.66K% |
| March 31, 2019 | -783.1% |
| December 31, 2018 | -844.3% |
| September 30, 2018 | -1.16K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -539.3% |
| Vaxcyte, Inc. | -- |
| Caribou Biosciences, Inc. | -1.62K% |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.24% |
| Return on Assets | -22.97% |
| Return on Invested Capital | -26.25% |
| Gross Profit Margin (Quarterly) | 98.83% |
| Operating Margin (Quarterly) | 31.22% |
| Return on Net Operating Assets | -176.5% |